Predictors of response to Infliximab in children with luminal Crohn's disease☆

Overview of attention for article published in Journal of Crohn's and Colitis Supplements, January 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,260 followers.

Durable response to Infliximab in luminal pediatric #Crohns #IBD was 70% after three years of maintenance therapy. http://t.co/Goim6joiSv

[Crohn's in Press] Predictors of response to Infliximab in children with luminal Crohn's disease - Corrected Proof http://t.co/PAKuKYYvkF

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.